Sleep apnoea machines for SDB patients | ResMed

Sleep apnoea devices

ResMed’s sleep apnoea therapy solutions are designed to offer a winning combination of advanced performance, comfort and efficient, user-friendly monitoring. Our sleep apnoea machines are suitable for patients with sleep-disordered breathing conditions.

AirSense 11, designed for better starts and long-term care

ResMed AirSense 11 is designed to make it easier and more convenient for patients to start, acclimatise and adhere to therapy.1 It offers the latest ResMed PAP features and technologies as well as over-the-air upgrade capabilities to enable continual improvements in the future.

Sleep bilevel

Our bilevel devices are for patients who need positive airway pressure therapy but are unable to tolerate CPAP therapy. Designed with comfort in mind, a bilevel device from ResMed could offer them a good night’s sleep.

Adaptive servo-ventilation

Our responsive adaptive servo-ventilator* offers your patients the comfort of natural breathing patterns and the reassurance of advanced technologies. This device is suitable for a range of central breathing disorders.

Can’t find the product you’re looking for?

It might have been discontinued: please contact your ResMed sales representative for information. You can also visit our user guides and technical documents page to explore other resources.

Explore more products

Whether your patient needs mechanical ventilation at home, in hospital or on the move, our versatile ventilation devices provide effective therapy for a wide range of respiratory conditions.


Browse our selection of replaceable spare parts and device accessories to help ensure your patients’ equipment continues to work optimally. 


ResMed’s sleep apnoea and respiratory care masks are designed to provide comfortable and effective therapy. Learn more about wide range of full face masks, nasal masks and nasal pillows masks.


Please refer to the user guide for relevant information related to any warnings and precautions to be considered before and during use of the product. 


*ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.

  1. ResMed Air11 survey of 146 patients, conducted from 28 June to 29 July 2021. Q19: 62% of patients reported that they felt confident about starting PAP therapy after being set up on AirSense 11, N=119 respondents. Q10: 63% of patients said that PTA gave them confidence to set up their PAP machine correctly, N=49 respondents. Data on file; ID A5043180.